title: Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis.
authors.forename: Kayoko
authors.initials: K
authors.lastname: Matsumura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nakase
authors.forename: Shuji
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Takuya
authors.initials: T
authors.lastname: Yoshino
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Takeda
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Kasahara
authors.forename: Satoru
authors.initials: S
authors.lastname: Ueno
authors.forename: Norimitsu
authors.initials: N
authors.lastname: Uza
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Chiba
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000209:etiology* / Q000276:immunology; D000069285:Infliximab; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab